Jim Pearson and Joseph Mark Reunite to Expand HoloMD's AI-Driven Psychiatry Platform for Healthcare Innovation

Written by Emily J. Thompson, Senior Investment Analyst

Source: Businesswire

Updated: Oct 28 2025

0mins

Should l Buy ?

Source: Businesswire

Leadership Appointment: HoloMD has appointed Jim Pearson as Executive Chairman, reuniting him with collaborator Joseph Mark, as they aim to tackle significant challenges in behavioral health using AI technology.
Addressing Mental Health Needs: The platform aims to bridge the gap in mental health care by providing ongoing, personalized support through its AI-driven virtual psychiatric assistant, Dr. Holo™, which enhances patient engagement and clinician insights.
AI-Powered Benefits: HoloMD's AI platform is designed to improve patient outcomes, provide valuable insights for healthcare providers, and enhance operational efficiency for organizations and payers.
Company Overview: Founded in July 2024, HoloMD is a HIPAA-compliant company with a patent-pending AI psychiatry platform that focuses on continuous patient engagement and treatment adherence, currently holding multiple patents and trademarks.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free